TETRAULT LYNN A. sold 84.1% of their position (37K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.71M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001104659-26-077305
Director
Since Dec 2020
-37K
Net shares
Net seller
$3.71M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
37K acquired · 74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37K
Price / share
$28.27
Trade value
$1.05M
% of position
528.6%
6/22/2026
7K→44K
Common Stock
Direct
Shares
−37K
Price / share
$100.32
Trade value
$3.71M
% of position
84.1%
6/22/2026
44K→7K
Total
Net shares
+0.00
Net value
-$2.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | M · Option Exercise | +37K | $28.27 | $1.05M | 528.6% | 7K | 44K |
| Common Stock Direct | 6/22/2026 | S · Sale | −37K | $100.32 | $3.71M | 84.1% | 44K | 7K |
| Total | +0.00 | -$2.67M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
37K shares
Shares
−37K
Strike price
28.27
Held after
0.00
Exercisable
—
6/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock37K shares | 6/22/2026 | M · Option Exercise | −37K | 28.27 | — | 0.00 |